Table I.
Drug-Using Experimental Group* |
Non-Using Comparison Group† |
|||||
---|---|---|---|---|---|---|
Analyte | Mean‡ | SD | N§ | Mean | SD | N |
Cocaine | ||||||
½ h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 4 |
1 h | 0.17 | 0.83 | 22 | 0.00 | 0.00 | 5 |
1½ h | 0.31 | 1.47 | 22 | 0.00 | 0.00 | 5 |
2 h | 0.36 | 1.01 | 22 | 0.00 | 0.00 | 5 |
1 day | 325.83 | 644.40 | 201 | 0.20 | 0.86 | 50 |
1 day (random) | 384.91 | 812.41 | 44 | 0.00 | 0.00 | 10 |
3 day | 816.93 | 1027.82 | 101 | 0.20 | 0.98 | 24 |
1 week | 1195.00 | 338.13 | 43 | 0.00 | 0.00 | 10 |
2 week | 1664.31 | 2330.26 | 19 | 5.83 | 11.45 | 4.00 |
Ecgonine methyl ester | ||||||
½ h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 4 |
1 h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 5 |
1½ h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 5 |
2 h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 5 |
1 day | 29.91 | 63.94 | 201 | 0.00 | 0.00 | 50 |
1 day (random) | 33.72 | 66.03 | 44 | 0.00 | 0.00 | 10 |
3 day | 83.11 | 115.28 | 101 | 0.00 | 0.00 | 24 |
1 week | 116.99 | 131.51 | 43 | 0.00 | 0.00 | 10 |
2 week | 210.96 | 279.52 | 19 | 0.00 | 0.00 | 4 |
Benzoylecgonine | ||||||
½ h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 4 |
1 h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 5 |
1½ h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 5 |
2 h | 0.00 | 0.00 | 22 | 0.00 | 0.00 | 5 |
1 day | 59.22 | 370.30 | 200 | 0.00 | 0.00 | 50 |
1 day (random) | 25.51 | 50.10 | 44 | 0.00 | 0.00 | 10 |
3 day | 168.16 | 461.69 | 101 | 0.00 | 0.00 | 24 |
1 week | 181.90 | 348.16 | 43 | 0.00 | 0.00 | 10 |
2 week | 723.61 | 748.63 | 19 | 0.00 | 0.00 | 4 |
22 subjects.
5 subjects.
Analyte concentrations in nanograms per milliliter of sweat eluate.
Number of patches.